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Volume 53, Number 1 Abstracts 247Comparison of Effects of Statin Use on Mortality in Patients With
Peripheral Arterial Disease With Versus Without Elevated C-Reactive
Protein and D-Dimer Levels
Vidula H, Tian L, Liu K, et al. Am J Cardiol 2010;105:1348-52.
Conclusion: In patients with peripheral arterial disease (PAD), use of
statins is associated with lower all-cause mortality and cardiovascular mor-
tality compared with no use of statin medications. Baseline C-reactive
protein (CRP) or D-dimer levels do not influence a favorable association of
statin use on decreasing mortality in patients with PAD.
Summary:Men and women with PAD have increased levels of inflam-
matory biomarkers and D-dimer compared with those without PAD
(McDermott MM, et al, Am Heart J 2005;150:276-81). Such patients repre-
sent an ideal core to study associations between statin therapy, mortality, and
biomarker levels. The authors used data from patients with PAD participat-
ing in the Walking and Leg Circulation Studies 1 and 2 (McDermott MM,
JAMA 2004;292:453-61; and McDermott MM et al, J Am Geriatric Soc
2007;55:400-6). PAD was defined as an ankle-brachial index (ABI) of
0.90. There were 579 participants with lower extremity PAD who were
stratified according to the presence and absence of elevated CRP and
D-dimer levels. Statin use was determined at baseline and at each annual
visit. CRP and D-dimer levels were measured at baseline. Mean follow-up
was 3.7 years. Analyses were adjusted for cholesterol levels, ABI, comorbidi-
ties, race, gender, and age. At baseline, 242 participants (42%) were taking a
statin, and 129 (22%) died during follow-up. Statin use was associated with
lower all-cause mortality (hazard ratio [HR], 0.51; 95% confidence interval
[CI], 0.30-0.86, P .012) and cardiovascular disease mortality (HR, 0.36;
95% CI, 0.14-0.89; P  .027) compared with nonstatin use. Statin therapy
was associated with significantly lower total and all-cause mortality only in
participants with baseline CRP levels greater than the median. Those with
CRP levels less than the median did not have improvement in mortality with
statin use, with HRs of 0.44 (95% CI, 0.23-0.88) vs 0.73 (95% CI 0.31-
1.75) for all cause mortality and HRs of 0.20 (95% CI, 0.063-0.65) vs 0.59
(95% CI 0.093-3.79) for cardiovascular disease mortality.
Comment: The findings are consistent with the results of the Justifi-
cation for the Use of statins in Patients: an Intervention Trial evaluating
Rosuvastatin (JUPITER) trial. The JUPITER trial, now being heavily
criticized for potential irregularities in statistical analysis and author conflict
of interest, demonstrated reduced cardiovascular events in patients with
relatively low cholesterol levels who had elevated CRP levels. Patients in
JUPITER did not have PAD, whereas all had PAD in this trial. The data
suggest the relative benefit of statin therapy may be greater in persons with
CRP levels greater thenmedian. Relative benefits of statin therapy in patients
with high vs low CRP levels, however, were not statistically significant but
may reflect insufficient power in the study. At this point, the study can be
regarded as extending the results of JUPITER to patients with PAD and
provides evidence for routine use of statin therapy in patients with PAD
regardless of cholesterol levels.
Cost-Effectiveness Analysis of General Anesthesia Versus Local Anaes-
thesia for Carotid Surgery (GALA Trial)
Gomes M, Soares MO, Dumville JC, and the GALA Collaborative Group.
Br J Surg 2010;97:1218-25.
Conclusion: In patients undergoing carotid endarterectomy (CEA), in
whom either general or local anesthesia is clinically appropriate, local anes-
thesia is likely more cost-effective.
Summary: Studies have indicated CEA is cost-effective relative to
medical management in treatment of both symptomatic and asymptomatic
patients with significant internal carotid artery (ICA) occlusive disease
(Cronenwett JL, et al, J Vasc Surg 1997;25:298-309; and Henricksson M,
et al, Br J Surg 2008;95:714-20).
The GALA trial was a large international randomized trial with 3526
subjects that compared general and local anesthesia for CEA. The trial found
no clear difference in perioperative events when CEA was performed with
local vs general anesthesia. In this secondary analysis, the authors sought to
determine cost-effectiveness of CEA under general vs local anesthesia in
patients undergoing CEA. Cost-effectiveness outcome was incremental cost
per day from an event 30 days. Cost-perspective for the trial was an
economic evaluation of that of the UKNational Health Service and personal
social services. Analysis was conducted using at 2003-2004 prices (£ ster-
ling), the midpoint of the GALA trial. The authors determined a patient
undergoing CEA under local anesthesia incurred fewer costs (mean differ-
ence, £178) and had slightly longer event-free survival (difference, 0.16
days) compared with patients who had general anesthesia. The willingness to
adopt local anesthesia over a wide range of willingness to pay values did not
have a significant effect.
Comment:The cost data here are 7 to 8 years old. Themedian hospital
length of stay in this trial for patients undergoing CEA with local or general
anesthesia was 6 days; an extraordinarily long time by current standards. The
conclusion that local anesthesia is more cost-effective than general anesthesia
based on these data is likely suspect now. The data cannot be used to justify
one form of anesthetic over another for the performance of CEA. Surgeonsand anesthesiologists should continue to use the anesthetic technique that
they are most comfortable with because clinical end points appear to be the
same with local and general anesthesia for CEA.
Detecting Traumatic Internal Carotid Artery Dissection Using Trans-
cranial Doppler in Head-Injured Patients
Bouzat P, Francony G, Brun J, et al. Intensive Care Med 2010;36:1514-20.
Conclusion: Asymmetry of systolic blood flow velocities between
middle cerebral arteries and a reduced pulsatility index suggest the presence
of traumatic internal carotid artery (ICA) dissection in a head-injured
patient.
Summary: Traumatic ICA dissection (TICAD) is an important cause
of stroke in young people, accounting for 20% of all strokes in younger
patients (Arthurs ZM, et al, Injury 2008;39:1232-241; and Menon RK, et
al, Ann N Y Acad Sci 2008;1142:200-17). Diagnosis of TICAD may be
delayed because of concurrent facial and cranial injuries, with symptoms
presenting as unexpected neurologic deficits up to 1-week after injury. In
many institutions, computed tomography angiography (CTA) is used to
screen for TICAD. Transcranial Doppler (TCD) studies are also frequently
used in the monitoring of head-injured patients. Two case reports have
suggested asymmetric mean blood flow velocities between middle cerebral
arteries, as determined by TCD imaging, may be helpful in the diagnosis of
TICAD (Achtereekte HA, et al, Surg Neurol 1994;42:240-4; and Romner
B, Acta Neurochir [Wien] 126:185-91). The authors of this article routinely
perform TCD measurements on all patients admitted to their emergency
department for head injury. Using this material, they conducted a retrospec-
tive matched cohort study in search for TCD abnormalities in patients in
whom TICAD was subsequently confirmed by CTA.
The study design was a retrospective 1-4 matched (age, mean arterial
blood pressure) cohort study of 11 traumatic brain injured (TBI) patients
with TICAD and absent or mild brain lesions on their initial CT scan. There
were 22 TBI controls with comparable brain lesions identified by CT scan
(control group 1) and an additional 22 TBI controls with more severe brain
lesions identified on CT scan (control group 2). Middle cerebral artery
measurements were obtained with TCD on admission. CTA was subse-
quently performed to diagnose TICAD. Of 11 patients with TICAD, 9 had
25% asymmetry of systolic blood flow velocity between the right and left
middle cerebral arteries. This asymmetry was found in 0 of 22 in control
group 1 and in 5 of 22 patients in control group 2 (P  .01). The
combination of this asymmetry with an ipsilateral pulsatility index (PI) of
0.8 [PI (time average systolic velocity – time average diastolic velocity)/
time-averaged mean velocity] was found in 9 of 11 with TICAD and in no
patients in control groups 1 or 2 (P  .01).
Comment: The results may be less useful in centers where CTA is
performed as a screening test in patients with head injury. Nevertheless,
CTAs can be difficult to interpret when evaluating for carotid dissection. The
study suggests that TCDmay be an important adjunctive test to confirm the
suspicion of TICAD in cases where CTA is not clearly diagnostic. The
number of patients is small in this series, and confirmatory studies will
be required. The data are, however, interesting and suggest potential ex-
panded application of transcranial Doppler technology.
External Carotid Artery Stenting to Treat Patients With Symptomatic
Ipsilateral Internal Carotid Artery Occlusion: A Multicenter Case
Series
Xu DS, Abruzzo TA, Albuquerque FC, et al. Neurosurgery 2010;67:
314-21.
Conclusion: Stenting of the external carotid artery (ECA) in the face of
symptomatic ipsilateral internal carotid artery (ICA) occlusion can be effec-
tive in some patients to relieve ischemic symptoms.
Summary: The ECA is a significant extracranial-to-intracranial collat-
eral source for the brain when the ICA is occluded. It may contribute, under
those circumstances, 10% to 15% of middle cerebral artery blood flow (Fearn
SJ, et al, J Vasc Surg 2000;31:989-93). Chronic neurologic symptoms
ipsilateral to the combination of a ICA occlusion and ECA stenosis may be
due to emboli originating from the ECA, emboli from a stump of the ICA,
or direct reduction of collateral perfusion (Street DL, et al, J Vasc Surg
1987;6:280-2; and Nano G, et al, Cardiovasc Internvent Radiol 2006;29:
140-2). Surgical treatment of ECA stenosis is infrequently performed but is
a well-known and recognized procedure. However, endovascular manage-
ment of ECA stenosis with angioplasty and stenting is a rare procedure. For
this report, the authors gathered data from five academic medical centers to
identify patients who underwent ECA stenting after 1998 and correlated
clinical data, procedural details, and follow-up results for analysis. Half the
patients came from a single medical center, with no more than three patients
from each of the other four contributing institutions.
There were 12 patients with a median age of 66 years (range, 45-79
years). Of these, 11 had ECA stenosis 70%, and all had ipsilateral ICA
occlusion. Symptoms included amaurosis fugax, stroke, and transient isch-
emic attack. After endovascular treatment, there was resolution of symptoms
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months). One patient’s procedure was complicated by aphasia and contralat-
eral hemiplegia. This patient also subsequently developed a contralateral
stroke and died 4 months after the procedure. An additional patient devel-
oped ipsilateral TIAs 3 weeks after stenting and subsequently underwent an
extracranial-to-intracranial bypass, with no further symptoms. There was no
apparent symptomatic in-stent restenosis, although50% in-stent restenosis
was noted in two patients on follow-up.
Comment: Stenting of the ECA is an unusual procedure. (The article
actually has more authors, 14, than patients, 12!) The results are certainly
not a mandate for ECA stenting for apparently symptomatic ECA stenosis.
However, there are also no compelling data for open revascularization of the
ECA. Revascularization of the ECA, whether by endovascular or open
surgical treatment, is supported by nothing more than individual case series
and is never likely to be supported by anything other than case series.
Use of Baseline Factors to Predict Complications and Reinterventions
After Endovascular Repair of Abdominal Aneurysm
Brown LC, Greenhalgh RM, Powell JT, and the EVARTrial Participants. Br
J Surg 2010;97:1207-17.
Conclusion: Graft-related complications and reinterventions after en-
dovascular aneurysm repair (EVAR) are more common in older patients and
in patients with larger aneurysms.
Summary: The authors sought to determine baseline factors that were
associated with graft-related complications and reinterventions after EVAR.
The analysis consisted of patients randomized to elective EVAR in the EVAR
1 or 2 trials. Patients were followed-up for serious graft-related complica-
tions, defined as graft rupture, proximal or distal graft migration, proximal or
distal type 1 endoleak, type 3 endoleak (loss of structural integrity, modulardisconnection, stent fracture, fabric tear or holes), graft kinking or throm-
bosis, graft infection, renal infarction, unsuccessful deployment, and con-
version to open repair for any complication, including type 2 endoleak or
endotension. Patients were also followed-up for reintervention. Reinterven-
tion criteria were not specified in the original EVAR trial protocols, and
reinterventions were based on local decisions. Cox regression analysis was
used to investigate if prespecified baseline factors were associated with time,
serious complication, or reintervention.
A total of 756 patients had elective EVAR and were followed-up for a
mean of 3.7 years. There were 179 serious graft complications (rate, 6.5/
100 person-years) and 114 reinterventions (rate, 3.8/100 person-years).
The highest rates were during the first 6 months, with apparent increased
rates again after 2 years. Multivariable analysis indicated graft-related com-
plications increased with larger initial aneurysm diameter (P  .001) and
older age (P .040). Some evidence suggested that patients treated with the
Excluder device (W.L. Gore & Associates, Flagstaff, Ariz) had lower rates of
complications and reinterventions compared with other graft types. Patients
with larger common iliac diameters also appeared to experience higher
complication rates (P  .011).
Comment: The association of increasing aneurysm diameter and in-
creasing age with complication and reintervention rates after EVAR stand
out as the most telling findings in this study. The results, however, really
cannot be construed to justify EVAR in younger patients with small abdom-
inal aortic aneurysms, because rupture rates are low in these patients (Powell
JT, Br J Surg 2007;94:702-8; and Lederle FA, N Engl J Med 2002;346:
1437-44). It also important to note that the inclusion criteria for patients in
the EVAR 1 and 2 trials were relatively strict. Relaxing anatomic selection
criteria undoubtedly will result in higher complication and reintervention
rates. Appropriate selection of anatomically suitable patients for EVAR
remains crucial to the long-term success of the procedure.
